Consumers who have X10 Natural Enhancement Supplement should stop using it and destroy or dispose of the product. The affected lots are F090824LN16, expiring in August 2026; F170325LN19, expiring in March 2027; and F300326LN28, expiring in March 2028. People who believe they have experienced a related health problem should contact a physician or other health care provider and may report adverse reactions or product-quality concerns through the FDA MedWatch program.
How to identify X10
The recalled item is a liquid packaged in a red-and-gold box with seven red, lightning-bolt-shaped packets. Each packet contains about 15 milliliters, and the product’s UPC is 7708075247094. Its original Spanish-language package describes it as “Bebida energizante,” or an energy beverage, according to the FDA recall notice.
The three affected lots were sold to consumers in the United States through Amazon, Walmart.com and naturefuel.us from Dec. 15, 2024, through June 11, 2026. Consumers who still have the product should compare its lot number with the recalled numbers before disposing of it.
What testing found
A&P Creations LLC, based in Clermont, Florida, recalled X10 after FDA laboratory testing detected sildenafil and tadalafil that were absent from the product label. Those substances are the active ingredients in Viagra and Cialis, respectively, prescription medicines used to treat erectile dysfunction, the FDA says.
The FDA warns that the undisclosed ingredients may interact with nitrates in prescription medicines, including nitroglycerin, and could lower blood pressure to dangerous levels. Its consumer safety notice also advises people to avoid the product and report suspected problems through MedWatch.
Company response
A&P Creations said it purchased and distributed X10 as a finished product but did not manufacture or formulate it. The company has ended distribution and is notifying affected customers directly and through the applicable online-marketplace procedures, according to the FDA announcement.
As of Sept. 14, A&P Creations said it had received no reports of adverse events connected with the recall. The company is accepting questions by email Monday through Friday from 9 a.m. to 4 p.m. Eastern time.
